BioAdaptives Inc
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a … Read more
BioAdaptives Inc (BDPT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.103x
Based on the latest financial reports, BioAdaptives Inc (BDPT) has a cash flow conversion efficiency ratio of 0.103x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-151.31K) by net assets ($-1.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioAdaptives Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how BioAdaptives Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioAdaptives Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioAdaptives Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Focus Home Interactive Société anonyme
STU:0HF
|
0.011x |
|
Sparindex INDEX Europa Forsvar
CO:SPIIEF
|
N/A |
|
NHK SPRING (NHK.SG)
STU:NHK
|
N/A |
|
Technoplus Ventures Ltd
TA:TNPV
|
0.010x |
|
Amphastar Pharmaceuticals Inc
STU:29A
|
0.097x |
|
ROLLS-ROYCE HLDGS
MU:RRU
|
N/A |
|
Wealth Invest AKL AlphaCura 0/50/100 W
CO:WEIACW
|
N/A |
|
R STAHL N
BE:RSL2
|
-0.003x |
Annual Cash Flow Conversion Efficiency for BioAdaptives Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of BioAdaptives Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.46 Million | $-249.52K | 0.170x | +25.42% |
| 2023-12-31 | $-1.65 Million | $-223.77K | 0.136x | -13.20% |
| 2022-12-31 | $-1.45 Million | $-227.26K | 0.157x | +7.87% |
| 2021-12-31 | $-1.09 Million | $-158.65K | 0.145x | +87.23% |
| 2020-12-31 | $-1.38 Million | $-106.89K | 0.078x | -61.27% |
| 2019-12-31 | $-839.88K | $-168.12K | 0.200x | -65.47% |
| 2018-12-31 | $-693.74K | $-402.14K | 0.580x | +476.25% |
| 2017-12-31 | $3.50K | $-540.00 | -0.154x | -387.55% |
| 2016-12-31 | $-176.36K | $5.57K | -0.032x | -9025.90% |
| 2015-12-31 | $-203.37K | $-72.00 | 0.000x | -100.00% |
| 2014-12-31 | $-117.00 | $-58.63K | 501.094x | +170299.21% |
| 2013-12-31 | $88.47K | $-26.05K | -0.294x | -- |